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ABSTRACT
Purpose To develop a stable micellar formulation of vitamin
K for oral delivery, because the commercial and clinically
used formulation of vitamin K (Konakion® MM) destabilizes
at gastric pH resulting in low bioavailability of this vitamin in
neonates with cholestasis.
Methods Mixed micelles composed of EPC, DSPE-PEG
2000 and glycocholic acid, with and without vitamin K, were
prepared by a film hydration method. The influence of pH on
the stability of the micelles was analyzed by dynamic light
scattering (DLS). The critical micelle concentration (CMC)
was determined by fluorescence spectroscopy using pyrene
and the morphology was evaluated by transmission electron
microscopy . Caco-2 cells were used to study the
cytocompatibilty.
Results Mixed micelles with mean diameters from 7.1 to
11.0 nm and a narrow size distribution (PDI<0.2) were ob-
tained after 3 membrane extrusion cycles. Konakion® MM
formed aggregated particles at gastric pH, which was avoided
through steric stabilization by introducing PEG. TEM
showed that mixed micelles had a spherical size (diameter of
around 10 nm) with a narrow size distribution in agreement
with the DLS results. The loading capacities for vitamin K of
mixed micelles with varying molar fractions of DSPE-PEG
and EPC (from 0/100 to 50/50 (mol/mol)) were 10.8–5.0
w%, respectively. The mixed micelles showed good
cytocompatibility at concentrations of glycocholic acid be-
tween 0.12 and 1.20 mM.
Conclusions Mixed micelles with superior stability to
Konakion® MM at low pH were obtained by introducing
DSPE-PEG 2000. These are therefore attractive oral formu-
lations for vitamin K.
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TEM Transmission electron microscopy
DLS Dynamic light scattering
CMC The critical micelle concentration




Ao Polar surface cross-area
L Length of the hydrophobic chain
FaSSGF Fasted state simulated gastric fluid





Vitamin K is an essential cofactor for γ-glutamyl carboxylase,
an enzyme that catalyzes the carboxylation of glutamic acid
residues in a number of proteins that are involved in the blood
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coagulation (1). In healthy adults, bile that is secreted into the
intestine facilitates the solubilization, transport and uptake of
vitamin K present in food (2). Therefore, dietary deficiency of
vitamin K is rare in adults, except for patients suffering from
intestinal disorders and malabsorption (3). On the other hand,
vitamin K deficiency does frequently occur in neonates due to
limited transport of vitamin K through the placental barrier
and low concentration in breast milk (main exogenous source
of vitamin K in neonates) (4). This in turn is associated with
the risk of life-threatening vitamin K deficiency bleeding
(VKDB), which is due to the low activity of vitamin K-
dependent coagulation factors (II, VII, IX, X) (5).
Konakion® mixed micelles (MM) Paediatric is a formulation
composed of vitamin K, egg phosphatidylcholine (EPC or
lecithin) and glycocholic acid (6). It is indicated for both the
prophylaxis and treatment of VKDB in neonates as well as
infants. However, orally administered Konakion® MM fails
to prevent VKDB in cholestatic infants due to impaired intes-
tinal absorption of vitamin K (7), which is due to the patho-
physiological conditions in the upper gastrointestinal tract of
those infants. Glycocholic acid has a carboxylic acid group
with a pKa of 3.8 (8), which ensures a good colloidal stability
of the mixed micelles above pH>~4. However, Konakion®
MM is unstable and forms large aggregates at low pH of the
stomach because of the protonation of the carboxylate group
of glycocholic acid, eventually causing coalescence of the for-
mulation (9). After stomach passage, large aggregates of lipids
and coalesced vitamin K enter the duodenum, which under
normal physiological conditions can subsequently be solubi-
lized by endogenous bile salts (10,11), pancreatic lipases and
elevated pH above the pKa of glycocholic acid (12,13). On the
other hand, once large aggregates are formed in the stomach
of neonates suffering from cholestasis, coalesced vitamin K
cannot be solubilized due to the very low level of bile salts in
these patients (13,14).
Mixed micelles composed of phospholipids and bile salts
were first described by Hoffman and Borgstrom (15) as asso-
ciated amphiphilic biliary and dietary components. The hy-
drophobic tails of EPCmolecules are positioned in the core of
the mixed micelles to minimize their contact with water mol-
ecules while their polar head groups are present at the inter-
face with water (16). It has been further shown that phospho-
lipids self-assemble into bilayered structures in aqueous solu-
tion, whereas mixed micelles are formed in the presence of
bile salts (16). These structures can solubilize poorly water-
soluble drugs in the inner micellar core (17). Furthermore,
mixed micelles are thermodynamically stable with sizes usual-
ly ranging from 5 to 60 nm (18). Particles with such small
diameters are necessary to transport vitamin K to the surface
of enterocytes and to retain mixed micelles at the base of
microvilli (19).
The aim of this study was to develop a mixed micellar
formulation of vitamin K that is stable at low pH and
therefore suitable for oral administration. Therefore, part of
EPC of the Konakion®MM formulation was substituted by a
PEGylated lipid (DSPE-PEG 2000). The rationale behind this
idea is that PEGylated phospholipids are known to act as a
steric barrier stabilizing nanostructures such as liposomes
(20,21), micelles (22), disks (23) and dendritic nanocarriers
(24), and will thereby enhance the stability of drug loaded
formulations at neutral as well as acidic pH. For example,
Torchilin et al. have shown that DSPE-PEG 2000/D-α-
tocopheryl PEG 1000 succinate (TPGS) micelles are stable
at low pH (25). PEGylated lipids have so far not been a com-
ponent of endogenous lecithin/bile salt mixed micelles to en-
hance their stability at low pH. Yet, those bile salt-lipids based
mixed micelles expose unique possibilities to enhance the per-
meability of hydrophobic drugs in the intestine (26).
Furthermore, EPC, glycocholic acid and DSPE-PEG 2000
are all components approved by U.S. FDA. Therefore, to
mimic the endogenous mixed micelles, a mixed micellar for-
mulation based on above components for vitamin K is pre-
ferred instead of for instance polymeric micelles, which can
also remain stable at acidic condition.
The size and pH stability of mixed micelles composed of
varying ratios of DSPE-PEG/EPCwere analyzed by dynamic
light scattering (DLS). Extrusion effects on the size of mixed
micelles during filtration were investigated using DLS and
TEM. The loading capacity of vitamin K for mixed micelles
composed of DSPE-PEG /EPC 50/50 (mol/mol) was opti-
mized. Furthermore, cell viability studies were conducted with




Lecithin (egg phosphatidylcholine, EPC) and 1,2-distearoyl-
sn-glycero-3-phosphoethanolamine-poly(ethylene glycol)
2000 (DSPE-PEG 2000) were kindly provided by Lipoid
GmbH (Ludwigshafen, Germany). Potassium phosphate
monobasic (KH2PO4) and sodium phosphate dibasic
dihydrate (Na2HPO4 · 2H2O) were purchased from Sigma-
Aldrich (Zwijndrecht, The Netherlands) and used to prepare
0.067 M phosphate buffer (0.35 g KH2PO4 and 1.45 g
Na2HPO4 · 2H2O in 100 ml RO-water, pH 7.3). Sodium
chloride were purchased from Merck KGaA (Darmstadt,
Germany). Sodium phosphate monobasic monohydrate
(NaH2PO4 ·H2O) and Pepsin from porcine stomach mucosa
wa s p rov ided by S igma-A ld r i ch (Zw i jndrech t ,
The Netherlands). Vitamin K, glycocholic acid hydrate, fetal
bovine serum (FBS) and all other chemicals and reagents were
o b t a i n e d f r om S i gma -A l d r i c h ( Zw i j n d r e c h t ,
The Netherlands). Chloroform was provided from Biosolve
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(Valkenswaard, the Netherlands). Sodium hydroxide
(NaOH), 70% perchloric acid, hexa-ammoniummolybdate
((NH4)6 MO7O24 · H2O) and ethanol were supplied by
Merck KGaA (Darmstadt , Germany ) . N -Methy l
dibenzopyrazine methylsulfate (PMS) and sodium
3′-[1-(phenylaminocarbonyl)-3,4-tetrazolium]-bis(4-methoxy-
6-nitro)benzene sulfonic acid hydrate) (XTT) were provided
from Sigma. Dulbecco’s Modified Eagle’s Medium (DMEM)
and RPMI 1640 medium were purchased from GibCo BRL
Life Technologies (Carlsbad, CA, USA). Syringe filters were
obtained from Phenomenex (0.2 μm, Torrance, CA).
Ultrapure water was produced by a Synergy UV water deliv-
ery system from Millipore (Billerica, MA, USA). Konakion®
MM was a product manufactured by Roche (Basel,
Switzerland).
METHODS
Preparation of Empty Micelles
Various amounts of EPC and DSPE-PEG 2000 were dis-
solved in 4 ml chloroform in a round-bottom flask (Table I).
The solvent was evaporated under vacuum at 60°C for
20 min to form a film. Next, glycocholic acid hydrate
(110 mg) was dissolved in 8 ml 0.067 M phosphate buffer at
60°C and the obtained solution was subsequently added to
hydrate the above mentioned film of EPC and DSPE-PEG
2000. A transparent dispersion was obtained after magnetical-
ly stirring for at least 4 h at room temperature. The dispersion
was subsequently extruded 3 times through a syringe filter.
Preparation of Vitamin K Loaded Micelles
Vitamin K (1 g) was dissolved in 10 ml chloroform. Next,
0.2 ml of this vitamin K solution was added to 3.8 ml chloro-
form in which the different amounts of lipids (EPC andDSPE-
PEG 2000) were dissolved (Table I). The solvent was evapo-
rated under vacuum at 60°C for 20 min to form a film. Next,
glycocholic acid hydrate (110 mg, 0.24 mmol) was dissolved in
8 ml 0.067 M phosphate buffer at 60°C and the obtained
solution was subsequently added to hydrate the above men-
tioned film of EPC, DSPE-PEG 2000 and vitamin K. A trans-
parent dispersion was obtained after magnetically stirring for
at least 4 h at room temperature. The dispersion was subse-
quently extruded 3 times through a syringe filter. The disper-
sions were covered with aluminized foil to protect Vitamin K
against light-triggered degradation during the whole proce-
dure (27).
To investigate the vitamin K loading capacity of the
DSPE-PEG/EPC 50/50 mixed micelles, DSPE-PEG
(288 mg, 0.10 mmol) and EPC (80 mg, 0.10 mmol) were
dissolved in 4 ml chloroform in a round-bottom flask. Next,
0.4 or 0.8 ml of vitamin K stock solution (100 mg/ml in chlo-
roform) was added. The following steps were the same as
described above until a transparent dispersion was obtained.
Then the obtained micellar dispersions were further diluted
ten times with 0.067 M phosphate buffer before filtration to
avoid occulation of the filter. Subsequently, the dispersions
were extruded 6 times through a filter.
Characterization of Mixed Micelles
Average size and size distribution of the different mixed mi-
celles dispersed in 0.067 M phosphate buffer were measured
by Dynamic Light Scattering (DLS; Zetasizer 4000, Malvern
Instruments, Malvern, UK) at 25°C and at an angle of 90°.
The morphology of the mixed micelles was studied by
Transmission Electron Microscopy (TEM, Tecnai 10,
Philips, and 100 kV). The samples for TEM visualization were
prepared according to the following procedure. A sample of
the mixed micelles dispersion (10 μl) was pipetted onto
parafilm and a carbon-coated copper grid subsequently was
placed on the sample for 4 min. Next, the excess liquid was
removed by filter paper and subsequently the grid was nega-
tively stained by being placed on a 10 μl droplet of 2% uranyl
acetate in demineralized water for 1 min. Next, the excess
liquid was removed using a filter paper and the grid was dried
for 5 min at room temperature before the measurement. The
zeta-potential (ζ potential) of the mixed micelles was deter-
mined by Zetasizer (Malvern Instruments Ltd.). Prior to the
measurements, phosphate buffer was exchanged by 10 mM
Hepes buffer pH 7.4 using PD-10 column chromatography.
The instrument was calibrated using a standard (DTS1235,
−42.0±4.2 mV, Malvern Instruments, UK).
Determination of the Critical Micelle Concentration
(CMC)
The CMC of the mixed micelles was determined using pyrene
as a fluorescent probe (28). In detail, empty micelles composed
of EPC only and DSPE-PEG/EPC (50/50, mol/mol,
formulations A and D, Table I) were prepared as described in
the section BPreparation of Empty Micelles^. Next the micellar
Table I Mixed Micelles Composed of DSPE-PEG, EPC and Glycocholic
Acid
Component Formulations
A B C D
DSPE-PEG 2000 (mmol) – 0.02 0.06 0.10
EPC (mmol) 0.20 0.18 0.14 0.10
DSPE-PEG/EPC (mol/mol) 0/100 10/90 30/70 50/50
The amounts of glycocholic acid and total lipids in the formulations were 0.24
and 0.20 mmol, respectively
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dispersions were diluted with 0.067 M phosphate buffer to
different concentrations from 5.9 × 10−6 to 29.5 mM
glycocholic acid (and 5.2×10−6 to 25.8 mM total lipids).
Next, 18 μl of pyrene in acetone (1.8×10−4 M) was added to
4.5 ml of each micellar dispersion. The micellar dispersions
with pyrene were incubated for 20 h at room temperature in
the dark to allow evaporation of acetone. Fluorescence excita-
tion spectra of pyrene were recorded using a Horiba Fluorolog
fluorometer (at a 90° angle). The excitation spectra (300 to
360 nm with emission wavelength of 390 nm) were recorded
at 37°C. The excitation and emission band slits were 4 and
2 nm, respectively. The excitation intensity ratio of I338/I333
was plotted against the concentration of glycocholic acid to
determine the CMC, which was obtained as the point of inter-
section of two tangents drawn to the curve at high and low
concentrations, respectively (29).
Stability of the Micelles
Two milliliter of vitamin K loaded micellar dispersions com-
posed of various amounts of DSPE-PEG/EPC (see Table I,
prepared as described in section BPreparation of Vitamin K
Loaded Micelles^) were diluted 2.5 times by addition of 3 ml
0.067 M phosphate buffer. For pH stability study, the pH of
the micellar dispersions was stepwise lowered from 7.2 to 1.6
by addition of 1 M HCl. After each step, the dispersions were
incubated for 5 min at 25°C and the size of the micelles was
measured by DLS at the same temperature. Subsequently, the
pH of dispersions was raised stepwise from 1.6 to 7.0 by
adding 1 M NaOH and after each step the dispersions were
incubated for 5 min at 25°C before measuring the size of the
micelles. For determination of vitamin K recovery, the pH of
the mixed micelles was lowered to 1.6 with 1 M HCl and the
dispersions were subsequently incubated for 1 h at 37°C.
Subsequently, the dispersions were centrifuged at 1000×g for
1min and 0.1ml of the different supernatants was diluted with
1 ml ethanol to dissolve the mixed micelles and the vitamin K
content was measured by HPLC as described below.
To mimic gastric stability at in vivo conditions, fasted state
simulated gastric fluid (FaSSGF) was used, without bile salts
(30). 1.50 ml mixed micelles composed of EPC only
(Konakion®MM) and DSPE-PEG/EPC (50/50, mol/mol)
with different concentrations of vitamin K (from 0.625 to
5.0 mg/ml) was added to 0.75 ml FaSSGF (20.0 μM lecithin,
34.2 mM NaCl and 0.1 mg/ml Pepsin, pH 1.5) and 0.24 ml
1MHCL (to adjust pH to 1.5). The mixture was incubated at
37°C for 1 h with slow rotating.
Determination of Vitamin K by HPLC Analysis
The concentration of vitamin K in the dispersions of the dif-
ferent mixed micelles was determined by RP-HPLC after di-
lution with ethanol. A SunFire C18 column was used and
absorption at 254 nm was used for detection. The mobile
phase was ethanol/water (95/5, v/v). The column tempera-
ture was 30°C. The injection volume was 20 μl. A calibration
curve was obtained using vitamin K dissolved in ethanol with
concentrations ranging from 19.8 to 181.8 μg/ml.
Determination of Lipid Recovery
The lipid recovery was determined using a method based on
the colorimetric determination of PO4
3− according to Rouser
(31). The phospholipid content of the mixed micelles was de-
termined after destruction of the phospholipids with
perchloric acid (HCLO4) to yield inorganic phosphate.
Standard solutions were prepared as follows: 20/40/60/80/
100/120/160 μl of 0.5 mM phosphate solution (1.95 g
NaH2PO4
.H2O dissolved in 250 ml of RO-water and subse-
quently diluted 100 times with RO-water) was introduced in
triplicate in test-tubes. Test samples were prepared by dilution
of the micellar dispersions 2.5 times with RO-water and
1.8 ml of the diluted dispersion was subsequently desalted
using PD-10 column chromatography (Pharmacia). The col-
lected volume was 2.0 ml. Phosphate buffer (1.8 ml, 0.067 M)
was also desalted using PD-10 column chromatography as
control. Then, samples of the micellar dispersions and the
control sample were 10 times diluted with RO-water. Next,
samples of 190 μl of the diluted micellar dispersions and the
control were pipetted in triplicate into the test tubes. The
tubes were covered by porcelain marbles and subsequently
heated using a block heater (Techne Dri-block heater,
Model DB 3H, PJ Brennan, Dublin) for 30 min (temperature
was set at 180°C). Next, the test tubes were cooled down to
room temperature and 0.3 ml of 70% perchloric acid was
introduced in the tubes. The tubes were again covered by
porcelain marbles and heated by the block heater (tempera-
ture at 180°C) for at least 45min until the solutions were clear.
N e x t , 1 m l RO - w a t e r , 0 . 5 m l 1 . 2% h e x a -
ammon i ummo l y bd a t e s o l u t i o n ( 1 . 2 5 g h e x a -
ammoniummolybdate in 100 ml of RO-water) and 0.5 ml of
5% (w/v) ascorbic acid (1.00 g in 20 ml of RO-water) were
added to the test tubes. Subsequently, the tubes were covered
by the porcelain marbles and placed in a water bath (100°C)
for 5 min. After cooling down to room temperature, the ab-
sorbance of the solutions at 797 nm was determined using a
UV–vis spectrophotometer (UV mini-1240, Shimadzu,
Japan) and the amount of phosphate in the samples was de-
termined using the calibration curve as described above.
Cytocompatibility of Vitamin K Loaded Mixed Micelles
The viability of Caco-2 cells incubated with vitamin K loaded
mixedmicelles was evaluated by the XTT assay (32). The cells
were seeded in 96-well plates at a density of 1×104 cells per
well and incubated at 37°C with 5% CO2 for 24 h to permit
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cells attachment. Because glychocholic acid is the main com-
ponent of the formulation which can cause cytotoxicity (33),
the concentration of the mixed micelles is reported in terms of
glycocholic acid content. Konakion® MM and vitamin K
loaded mixed micelles (2.5 mg/ml) composed of EPC only
and DSPE-PEG/EPC (10/90, 30/70 and 50/50, mol/mol,
respectively) were diluted with Dulbecco’s Modified Eagle’s
medium (blank DMEM). The final concentrations of
glycocholic acid of the mixed micelles were from 0.12 to
1.20 mM after addition of 20 μl samples to 100 μl DMEM
culture medium. The control was empty micelles composed of
DSPE-PEG/EPC (50/50, mol/mol) (final concentration of
glycocholic acid was 1.2 mM). To investigate the viability of
caco-2 cells at higher concentrations of mixedmicelles, formu-
lations composed of DSPE-PEG/EPC (50/50, mol/mol) and
EPC only were used. They were diluted with Dulbecco’s
Modified Eagle’s medium (blank DMEM) and their final con-
centrations of glycocholic acid were from 0.12 to 12 mM.
100 μl of above mixed micelles was added to each well.
After 24 h of culturing at 37°C, the medium was removed
and 50 μl XTT solution (1 mg/ml in plain RPMI 1640, con-
taining 25 μM PMS) was added per well and the plates were
subsequently incubated for 1.5 h at 37°C, after which the
absorbance at 490 nm with a reference wavelength of
655 nm was measured by ELISA microplate reader (Biorad
Novapath).
RESULTS AND DISCUSSION
Preparation of Mixed Micelles with and
Without Vitamin K Loading
Vitamin K loadedmixedmicelles composed of EPC, with and
without DSPE-PEG, and a fixed molar ratio of 0.22 vitamin
K versus total lipids, were prepared by hydration of a lipid film
with a glycocholic acid solution, resulting in turbid dispersions
probably consisting of large unilamellar liposomes coexisting
with flat bilayers as has been reported earlier (34,35). The
turbid dispersions became gradually translucent upon mag-
netic stirring, and finally transparent micellar dispersions were
obtained after stirring for 4 h. The average size of the dis-
persed particles after stirring for 4 h and before filtration was
between 85 and 215 nm (Fig. 1a) with high polydispersity
(Fig. 1b). Such high polydispersity suggests the coexistence of
micelles and larger vesicles.
There are at least two factors involved in the change from
turbid to transparent dispersions. First, the molecular volume
(V) of the phospholipid EPC is approximately equal to the
polar surface cross-area (Ao) and the length (L) of the hydro-
phobic chain, meaning that the packing parameter PP=V/
(Ao×L) (36), is close to 1 and as a consequence this phospho-
lipid tends to form planar bilayers (37). The insertion of
glycocholic acid in the phospholipid vesicles, due to its flat
structure, can increase Ao which results in a reduction of the
PP. As a consequence, part of the vesicles is transformed into
highly curved mixed micelles (38) as shown in Fig. 2a. This
glycocholic acid induced vesicles-to-micelles transition process
occurs in three steps (39). Glycocholic acid initially partitions
between water and the outermost planar bilayer and subse-
quently penetrates and peels off the planar lipid bilayers one
after the other yielding smaller bilayer flakes (stage 1).
Subsequently, after being peeled off, phospholipid molecules
and glycocholic acid molecules can self-assemble into micelles
by hydrophobic interaction (stage 2). The other factor of im-
portance is the presence of DSPE-PEG in planar bilayers.
Even at low ratios of DSPE-PEG (5 mol%) (40), its presence
reduces the size of planar bilayers composed of EPC (40) and
increases the curvature of the particles. With increasing
DSPE-PEG in the bilayer, the PP of mixed micelles decreases
and can reach a value of<0.5 (37). As a consequence, larger
vesicles and planar bilayers are transformed into smaller and
spherical micelles or cylindrical micelles (36) as shown in
Fig. 2a (39,40).
After filtration through a membrane with pores of 200 nm,
the average sizes of large particles composed of EPC and
DSPE-PEG decreased from 213±2 nm, 112±15 nm, 100
±21 nm and 132±69 nm to 7.1±0.2 nm, 8.9±0.4 nm, 9.7
±0.8 nm and 11.0±1.4 nm (n=3), respectively, for formula-
tions with DSPE-PEG/EPC molar ratios increasing from 0/
100 to 50/50 (Fig. 1a). The PDI also reduced substantially
from 0.60-0.87 to<0.26 (Fig. 1b). Figure 3 shows the calcu-
lated intensity weighted diameter before and after filtration
for formulations with different molar fractions of DSPE-
PEG. Before filtration, size distributions by intensity showed
that larger particles with diameters above 100 nm were pres-
ent. Importantly, the intensity of these larger particles
(>100 nm) decreased significantly and the intensity of the
smaller particles of ~10 nm increased correspondingly after
the first filtration. Finally, a fraction of large particles was not
detected anymore after 3 filtration cycles and only smaller
particles of ~10 nmwith a unimodal distribution were present
in the dispersions (Fig. 3). Through filtration, larger particles
like flat bilayers or vesicles are subjected to both mechanical
shear forces when pressed through the pores of the membrane
(41) and the high pressure differential (42) across the filter.
Spherical mixed micelles are likely being squeezed off from
the cylindrical micelles (43) during their passage through the
pores (Fig. 2b).
Lipids Recovery and Vitamin K Loading Capacity
The lipid recovery was determined according to Rouser (31).
For the mixed micelles with 0.22 molar ratio of vitamin K
versus total lipids, 91–96% of the lipids was recovered after 3
filtration cycles for the various mixed micelles (Fig. 4).
2172 Sun et al.
The vitamin K recovery, defined as the percentage of vita-
min K solubilized in the mixed micelles divided by the added
amount of vitamin K was 96–100% after three cycles of filtra-
tion (Fig. 4). The vitamin K loading capacity of the mixed
micelles, defined as the percentage the mass of vitamin K
divided by the total mass of the mixed micelles, decreased
from 10.8±0.5% to 5.0±0.2% with increasing molar frac-
tion of DSPE-PEG. The reason for this decrease in loading is
that the total mass of lipids increased when EPC was replaced
by higher-molecular-weight DSPE-PEG 2000.
To get insight into the maximum vitamin K loading capac-
ity of the mixed micelles composed of 50/50 DSPE-PEG/
EPC, an increasing amount of vitamin K was added to a fixed
amount of total lipids (molar ratio of vitaminK and total lipids
was increased from 0.22 to 0.44 and 0.88, respectively).
However, in that case, three more filtration cycles were need-
ed to remove large particles with size above 200 nm. Table II
shows that both the vitamin K recovery (91.3±2.0%), and the
lipid recovery (89.5±4.1%) was high after the 6 successive
filtration cycles when the feed of vitamin K was 0.44 (mol/
mol lipids). However, vitamin K recovery decreased signifi-
cantly to 42.6±1.5% and lipid recovery was 41.1±3.9%
when the feed of vitamin K was further increased to 0.88
(mol/mol lipids).
The size of empty micelles after 3 filtration cycles ranged
from 7.0±0.3 to 9.2±0.1 nm with increasing DSPE-PEG
content (Fig. 5a). The PDI was<0.2 for all empty micelles
(Fig. 5b). The size of vitamin K loaded micelles (at a feed of
0.22 molar ratio of vitamin K versus total lipids) after filtration
increased from 7.1±0.2 to 11.0±1.4 nm with increasing
DSPE-PEG content (Fig. 5a), which is in good agreement with
the average thickness of around 1.5–3.5 nm for PEG corona
of DSPE-PEG2000 (22,44). The PDI was <0.2 for all vitamin
K loaded micelles (Fig. 5b), which points to a narrow particle
size distribution. Figure 5c shows the zeta potentials of the
different micelles. The low zeta potential of −22.7±3.6 mV
for themixedmicelles composed of bile salt and EPC is caused
by deprotonation of the COOH groups of glycocholic acid in
Fig. 1 Z-average diameter (a) and
polydispersity index (PDI) (b) of
vitamin K loaded mixed micelles
composed of different molar ratio of
DSPE-PEG/EPC before and after
filtrations.
Fig. 2 A schematic mechanism of the formation of micelles from planar phospholipid bilayers during hydration of a film in a bile salt solution under stirring before
filtration (a), and the size reduction after repeated filtrations through a 0.2 μm filter (b).
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phosphate buffer. With an increase of the fraction of DSPE-
PEG from 0/100 to 50/50 (mol/mol) in the formulations, an
increase of zeta potential from −22.7±3.6 to −2.8±0.5 mV
was observed, demonstrating excellent shielding of the surface
charge by PEG.
When the feed of vitamin K increased from 0.22 to 0.44,
the average size of the mixed micelles increased from 11.0
±1.4 to 19±6 nm after 6 times filtration, because still a small
fraction of bigger particles between 100 and 200 nmwas pres-
ent even after 6 filtration cycles. The majority of particles
however had an average s i ze o f around 15 nm
(Supplementary Fig. 1a). When the feed of vitamin K further
increased from 0.44 to 0.88 (mol/mol lipids), the micellar
dispersions needed to be diluted to avoid occlusion during
the filtration. The average size of the mixed micelles ended
up at 44±5 nm after the six filtration cycles. The average size
of a minor fraction of micelles was around 18 nm but the
majority had a size of between 100 and 200 nm
(Supplementary Fig. 1b).
The morphology of the mixed micelles composed of
DSPE-PEG/EPC 50/50 (mol/mol) with vitamin K feed mo-
lar ratio of 0.22 (mol/mol lipids) was investigated by TEM
analysis (Fig. 6). Figure 6a (arrows) shows several large
particles of approximately 150 nm before filtration which con-
firmed the size as determined by DLS (Fig. 3d). After the first
filtration cycle, cylindrical structures of up to approximately
100 nm in length can be seen besides spherical micelles
(Fig. 6b), which are common shapes of mixed micelles
Fig. 3 Size intensity weighted diameter of different vitamin K loaded mixed micelles composed of EPC only (a), and DSPE-PEG/EPC with molar ratio’s 10/90
(b), 30/70 (c) and 50/50 (d) before and after 3 cycles of filtration, respectively.
Fig. 4 Vitamin K recovery/loading and lipid recovery of mixed micelles com-
posed of different molar ratio of DSPE-PEG/EPC (n=3 independently pre-
pared batches).
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composed of phospholipids and bile salts (40). One explana-
tion for the formation of cylindrical structures is that TEM
images show the shape of mixed micelles in their dry state.
Thus, during the evaporation of water for the preparation of
the specimen, increasingly higher concentrations of electro-
lytes such as phosphate buffer screen the electrostatic repul-
sion and promote particle aggregation (45). Also, PEG can
induce lipid fusion in the dry state (46,47), finally resulting in
cylindrical structures as shown in Fig. 6b. Importantly, after 3
filtration cycles, although the effect of drying on the shape of
micelles can also be observed in Fig. 6c, in which several small
mixed micelles fused into pearl-necklace-like structures are
seen (48), mostly spherically shapedmixed micelles with diam-
eter around 10 nm were present in the sample of Fig. 6c.
Like for conventional surfactants, the formation of mixed
micelles can be demonstrated using the fluorescent probe
pyrene. The pyrene fluorescence intensity ratio of I338/I333
is plotted as a function of concentration of glycocholic acid
in Supplementary Fig. 2. The CMC of mixed micelles com-
posed of EPC only was 4.6 μM glycocholic acid. For mixed
micelles composed of DSPE-PEG/EPC (50/50), their CMC
was 3.9 μM glycocholic acid. Within the experimental error,
the CMCs of both mixed micelles are equal.
Stability and Vitamin K Retention at Acid pH
To study the stability of various mixed micelles, size changes
were measured when the pH was stepwise decreased from 7.3
to 1.6 and subsequently reversed to 7.3. The size of micelles
composed of EPC only was 80 nm after the pHwas lowered to
Table II Influence of Vitamin K Feed (Molar Ratio of Vitamin K Versus Total
Lipids) on the Loading Capacity of Mixed Micelles Composed of DSPE-PEG/
EPC 50/50 (mol/mol) (n=3 Independently Prepared Batches)








0.22 98.4±2.8 96.3±0.4 5.0±0.2 11.0±1.4
0.44 91.3±2.0 89.5±4.1 9.9±0.2 19±6
0.88 42.6±1.5 41.1±3.9 18.4±0.5 44±5
Fig. 5 Z-average hydrodynamic diameter (a), polydispersity index (PDI) (b) and zeta potential (c) of mixed micelles with or without vitamin K as a function of
molar ratio of DSPE-PEG/EPC (n=3 independently prepared batches).
A Mixed Micelle Formulation for Oral Delivery of Vitamin K 2175
4.2 (Supplementary Fig. 3a), while turbidity appeared after
the pH was further lowered to 3.5 (Supplementary Fig. 4a).
Apparently, the micelles became unstable and aggregated or
coalesced, resulting in precipitation of vitamin K
(Supplementary Fig. 4b). The pH of the dispersions was then
stepwise lowered to 1.6 and they were subsequently incubated
for 1 h at 37°C. After centrifugation, the amount of vitamin K
in the supernatants as measured by HPLC was found to be
only 1.5±0.1 and 6.3±0.3% of the initial vitamin K loading
for the commercial formulation and mixed micelles composed
of EPC only, respectively (Supplementary Fig. 5).
For mixed micelles composed of DSPE-PEG/EPC 10/90
(mol/mol), their size increased from 9 to 100 nm and disper-
sions became translucent, when the pH was lowered stepwise
to 1.6 (Supplementary Fig. 3b). It was further measured that
58.2±0.9% of vitamin K remained solubilized in the mixed
micelles (Supplementary Fig. 5). Mixed micelles composed of
DSPE-PEG/EPC 30/70 (mol/mol) remained transparent
and the size increased only slightly from 10 to 20 nm when
the pH was lowered from 7.3 to 1.6 (Supplementary Fig. 3c).
The size remained around 20 nm (with PDI at around 0.2)
when the dispersions were kept at pH 1.6 at 37°C for 80 mins
(Supplementary Fig. 3e), and around 90% of vitamin K
remained solubilized at pH 1.6 (Supplementary Fig. 5).
Interestingly, the size of the mixed micelles composed of
DSPE-PEG/EPC 50/50 (mol/mol) did not show any change
when the pH was lowered from 7.3 to 1.6 and vice versa
(Supplementary Fig. 3d) and remained around 12 nm with
PDI of ~0.2 at pH 1.6 and 37°C for 80 min (Supplementary
Fig. 3f), while more than 90% of vitamin K remained solubi-
lized at pH 1.6 (Supplementary Fig. 5). The stability of mixed
micelles was further investigated in FaSSGF (pH 1.5).
Konakion® MM was not stable and coalescence of vitamin
K was observed within 1 h at 37°C (Fig. 7). However, mixed
micelles composed of 50/50 DSPE-PEG/EPC (mol/mol)
remained stable and kept transparent in FaSSGF for at least
a b cFig. 6 TEM images of vitamin K
loaded mixed micelles composed of
DSPE-PEG/EPC 50/50 and a
vitamin K feed molar ratio of 0.22
(mol/mol lipids): before filtration (a),
after the first filtration cycle (b) and
























efore diluted with FaSSGF After diluted with FaSSGF
Fig. 7 Photographs of mixed micelles composed of EPC only (Konakion® MM) and 50/50 DSPE-PEG/EPC (mol/mol) with different vitamin K concentrations
(from 0.625 to 5 mg/ml), incubated for 1 h at 37°C with and without FaSSGF.
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1 h at 37°C. To conclude, due to the steric stabilization of
mixed micelles by PEG, the formation of aggregated particles
can thus be avoided by introducing PEG in the formulation.
Cell Viability Study
The effect of vitamin K loaded mixed micelles of different
compositions as well as the commercial formulation
Konakion® MM on the viability of Caco-2 cells was studied
using theXTT assay. Caco-2 cells were selected as amodel for
small intestinal epithelial cells (49,50). As shown in Fig. 8a, the
cell viability after 24 h of incubation with different formula-
tions with concentration of glycocholic acid ranging from 0.12
to 1.20 mM was>90%. Figure 8b also shows the in vitro cell
viability of Caco-2 cells incubated with commercial formula-
tion Konakion® MM and mixed micelles composed of EPC
only or DSPE-PEG/EPC (50/50 mol/mol) at higher concen-
trations of glycocholic acid (from 0.12 to 12mM) for 24 h. Cell
viability decreased from 95 to 50% when the concentration of
glycocholic acid increased from 0.12 to 12 mM, respectively.
The reduced cell viability is due to high concentration of
glycocholic acid (33,51). Therefore, mixed micelles composed
of DSPE-PEG/EPC showed good cytocompatibility which is
comparable with that of the commercial formulation
Konakion® MM.
CONCLUSIONS
In this study, vitamin K loaded mixed micelles composed of
DSPE-PEG, EPC and glycocholic acid were successfully pre-
pared by a film hydration method. Extrusion through a mem-
brane filter plays a crucial role in preparation of mixed mi-
celles with final sizes at around 10 nm. Vitamin K loaded
mixed micelles composed of EPC, DSPE-PEG 2000 and
glycocholic acid showed high loading capacity and good
cytocompatibility for Caco-2 cells, which was comparable to
mixed micelles without DSPE-PEG (i.e. Konakion® MM).
Additionally, mixed micelles of EPC, DSPE-PEG 2000 and
glycocholic acid can prevent both the formation of larger ag-
gregates and coalescence of vitamin K in the micellar disper-
sions at low pH thus is superior to Konakion® MM with
regard to their gastric stability. Therefore, mixed micelles of
EPC, DSPE-PEG 2000 and glycocholic acid are a promising
oral formulation of vitamin K for the prophylaxis and treat-
ment of VKDB in neonates and infants suffering from chole-
stasis. More work about the intestinal transport of vitamin K
loaded mixed micelles composed of EPC, DSPE-PEG 2000
and glycocholic acid will be conducted in the near future.
ACKNOWLEDGMENTS AND DISCLOSURES
The research was partially supported by China Scholarship
Council.
OpenAccessThis article is distributed under the terms of the
Creative Commons Attribution 4.0 International License
(http://creativecommons.org/licenses/by/4.0/), which
permits unrestricted use, distribution, and reproduction in
any medium, provided you give appropriate credit to the
original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
REFERENCES
1. Vermeer C. Gamma-carboxyglutamate-containing proteins and
the vitamin K-dependent carboxylase. Biochem J. 1990;266:625.
Fig. 8 In vitro cell viability of Caco-2 cells incubated for 24 h with mixed micelles composed of EPC only and different molar ratio of DSPE-PEG/EPC (from10/90
to 50/50, mol/mol) and Konakion® MM.
A Mixed Micelle Formulation for Oral Delivery of Vitamin K 2177
2. Siperstein M, Chaikoff I, Reinhardt W. C14-Cholesterol. 5.
Obligatory function of bile in intestinal absorption of cholesterol.
J Biol Chem. 1952;198:111–4.
3. Shearer MJ. Vitamin K, in Parenteral Nutrition. Gastroenterology.
2009;137:105–18.
4. Lippi G, Franchini M. Vitamin K in neonates: facts and myths.
Blood Transfus. 2011;9:4.
5. Chalmers E. Neonatal coagulation problems. ArchDis Child-Fetal.
2004;89:475–8.
6. Available from: https://www.medicines.org.uk/emc/print-
document?documentId=1699
7. Von Kries R, Hachmeister A, Göbel U. Oral mixed micellar vita-
min K for prevention of late vitamin K deficiency bleeding. Arch
Dis Child-Fetal. 2003;88:109–12.
8. EckhardtU,Horz JA, Petzinger E, et al. The peptide based thrombin
inhibitor CRC 220 is a new substrate of the basolateral rat liver
organic anio-transporting polypeptide. Hepatology. 1996;24:380–4.
9. Van Hasselt PM. Vitamin K prophylaxis revisited: focus on risk
factors. 2009
10. Gothwal A, Khan I, Gupta U. Polymeric micelles: recent advance-
ments in the delivery of anticancer drugs. PharmRes. 2016;33:18–39.
11. Fagerberg JH, Karlsson E, Ulander J, Hanisch G, Bergström CA.
Computational prediction of drug solubility in fasted simulated and
aspirated human intestinal fluid. Pharm Res. 2015;32:578–89.
12. Iqbal J, Hussain MM. Intestinal lipid absorption. Am J Physiol
Endocrinol Metab. 2009;296:1183–94.
13. Werner A, Kuipers F, Verkade HJ. Fat absorption and lipid me-
tabolism in cholestasis. In: Trauner M, Jansen PLM, editors.
Molecular pathogenesis of cholestasis. New York: Landes
Bioscience; 2004. p. 314–28.
14. Hernell O, Staggers JE, Carey MC. Physical-chemical behavior of
dietary and biliary lipids during intestinal digestion and absorption.
2. Phase analysis and aggregation states of luminal lipids during
duodenal fat digestion in healthy adult human beings.
Biochemistry. 1990;29:2041–56.
15. Hofmann AF, Borgström B. The intraluminal phase of fat digestion
in man: the lipid content of the micellar and oil phases of intestinal
content obtained during fat digestion and absorption. J Clin Invest.
1964;43:247.
16. Madenci D, Salonen A, Schurtenberger P, Pedersen JS, Egelhaaf
SU. Simple model for the growth behaviour of mixed lecithin–bile
salt micelles. Phys Chem Chem Phys. 2011;13:3171–8.
17. Khan J, Rades T and Boyd B. The precipitation behavior of poorly
water-soluble drugs with an emphasis on the digestion of lipid based
formulations. Pharm Res. 2015: 1–15.
18. Rupp C, Steckel H, Müller BW. Solubilization of poorly water-
soluble drugs by mixed micelles based on hydrogenated phospha-
tidylcholine. Int J Pharm. 2010;395:272–80.
19. Hauss DJ. Oral lipid-based formulations: enhancing the bioavail-
ability of poorly water-soluble drugs. Boca Raton: CRC Press;
2007.
20. ImmordinoML, Dosio F, Cattel L. Stealth liposomes: review of the
basic science, rationale, and clinical applications, existing and po-
tential. Int J Nanomed. 2006;1:297.
21. Lindqvist A, Rip J, van Kregten J, Gaillard PJ, Hammarlund-
Udenaes M. In vivo functional evaluation of increased brain deliv-
ery of the opioid peptide DAMGO by Glutathione-PEGylated li-
posomes. Pharm Res. 2016;33:177–85.
22. Vukovic L, Khatib FA, Drake SP, et al. Structure and dynamics of
highly PEG-ylated sterically stabilized micelles in aqueous media. J
Am Chem Soc. 2011;133:13481–8.
23. Carmona-Ribeiro AM. Lipid bilayer fragments and disks in drug
delivery. Curr Med Chem. 2006;13:1359–70.
24. Pourjavadi A, Tehrani ZM,Moghanaki AA. Folate-conjugated pH-
Responsive nanocarrier designed for active tumor targeting and
controlled release of gemcitabine. Pharm Res. 2016;33:417–32.
25. Dabholkar RD, Sawant RM, Mongayt DA, et al. Polyethylene gly-
col phosphatidyl-ethanolamine conjugate (PEG-PE)-based mixed
micelles: some properties, loading with paclitaxel, and modulation
of P-glycoprotein-mediated efflux. Int J Pharm. 2006;315:148–57.
26. Dangi J, Vyas S, Dixit V. Effect of various lipid-bile salt mixed
micelles on the intestinal absorption of amphotericin-B in rat.
Drug Dev Ind Pharm. 1998;24:631–5.
27. Brodie AF, Ballantine J. Oxidative phosphorylation in fractionated
bacterial systems II. The role of vitamin K. J Biol Chem. 1960;235:
226–31.
28. KalyanasundaramK, Thomas J. Environmental effects on vibronic
band intensities in pyrene monomer fluorescence and their appli-
cation in studies of micellar systems. J Am Chem Soc. 1977;99:
2039–44.
29. Soga O, van Nostrum CF, Ramzi A, et al. Physicochemical charac-
terization of degradable thermosensitive polymeric micelles.
Langmuir. 2004;20:9388–95.
30. Vertzoni M, Dressman J, Butler J, et al. Simulation of fasting gastric
conditions and its importance for the in vivo dissolution of lipophilic
compounds. Eur J Pharm Biopharm. 2005;60:413–7.
31. Rouser G, Fleischer S, Yamamoto A. Two dimensional thin layer
chromatographic separation of polar lipids and determination of
phospholipids by phosphorus analysis of spots. Lipids. 1970;5:
494–6.
32. Scudiero DA, Shoemaker RH, Paull KD, et al. Evaluation of a
soluble tetrazolium/formazan assay for cell growth and drug sensi-
tivity in culture using human and other tumor cell lines. Cancer
Res. 1988;48:4827–33.
33. Tan Y, Qi J, Lu Y, Hu F, Yin Z, WuW. Lecithin in mixed micelles
attenuates the cytotoxicity of bile salts in Caco-2 cells. Toxicol
In Vitro. 2013;27:714–20.
34. Lichtenberg D, Ahyayauch H, Alonso A, Goñi FM. Detergent sol-
ubilization of lipid bilayers: a balance of driving forces. Trends
Biochem Sci. 2013;38:85–93.
35. Kozlov MM, Andelman D. Theory and phenomenology of mixed
amphiphilic aggregates. Curr Opin Colloid Interface Sci. 1996;1:
362–6.
36. Israelachvili JN. Intermolecular and surface forces: with applica-
tions to colloidal and biological systems (Colloid Science).
London: Academic; 1992.
37. Garbuzenko O, Barenholz Y, Priev A. Effect of grafted PEG on
liposome size and on compressibility and packing of lipid bilayer.
Chem Phys Lipids. 2005;135:117–29.
38. Jiang L, Wang K, Deng M, Wang Y, Huang J. Bile salt-induced
vesicle-to-micelle transition in catanionic surfactant systems: steric
and electrostatic interactions. Langmuir. 2008;24:4600–6.
39. Helenius A, Simons K. Solubilization of membranes by detergents.
BBA-Biomembr. 1975;415:29–79.
40. Johnsson M, Edwards K. Liposomes, disks, and spherical micelles:
aggregate structure in mixtures of gel phase phosphatidylcholines
and poly (ethylene glycol)-phospholipids. Biochem J. 2003;85:
3839–47.
41. Clerc SG, Thompson TE. A possible mechanism for vesicle forma-
tion by extrusion. Biochem J. 1994;67:475.
42. Patty PJ, Frisken BJ. The pressure-dependence of the size of extrud-
ed vesicles. Biochem J. 2003;85:996–1004.
43. Wickner W, Schekman R. Membrane fusion. Nat Struct Mol Biol.
2008;15:658–64.
44. Johnsson M, Hansson P, Edwards K. Spherical micelles and other
self-assembled structures in dilute aqueous mixtures of poly (ethyl-
ene glycol) lipids. J Phys Chem B. 2001;105:8420–30.
45. Cheng CY, Oh H, Wang TY, Raghavan SR, Tung SH. Mixtures
of lecithin and bile salt can form highly viscous wormlike micellar
solutions in water. Langmuir. 2014;30:10221–30.
2178 Sun et al.
46. Malinin VS, Frederik P, Lentz BR. Osmotic and curvature stress
affect PEG-induced fusion of lipid vesicles but not mixing of their
lipids. Biochem J. 2002;82:2090–100.
47. Burgess SW, McIntosh TJ, Lentz BR. Modulation of poly
(ethylene glycol)-induced fusion by membrane hydration: im-
portance of interbilayer separation. Biochemistry. 1992;31:
2653–61.
48. Chen Q, Zhao H, Ming T, Wang J, Wu C. Nanopore extrusion-
induced transition from spherical to cylindrical block copolymer
micelles. J Am Chem Soc. 2009;131:16650–1.
49. Artursson P. Epithelial transport of drugs in cell culture. I: a model
for studying the passive diffusion of drugs over intestinal absorbtive
(Caco-2) cells. J Pharm Sci. 1990;79:476–82.
50. Parr A, Hidalgo IJ, Bode C, et al. The effect of excipients on the
permeability of BCS Class III compounds and implications for
biowaivers. Pharm Res. 2016;33:167–76.
51. Jørgensen L, Artursson P, Bechgaard E. Toxicological and absorp-
tion enhancing effects of glycofurol 75 and sodium glycocholate in
monolayers of human intestinal epithelial (Caco-2) cells. Int J
Pharm. 1993;95:209–17.
A Mixed Micelle Formulation for Oral Delivery of Vitamin K 2179
